120 related articles for article (PubMed ID: 2510586)
1. Nigrostriatal function in humans studied with positron emission tomography.
Martin WR; Palmer MR; Patlak CS; Calne DB
Ann Neurol; 1989 Oct; 26(4):535-42. PubMed ID: 2510586
[TBL] [Abstract][Full Text] [Related]
2. Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren.
Cordes M; Snow BJ; Cooper S; Schulzer M; Pate BD; Ruth TJ; Calne DB
Ann Neurol; 1994 Oct; 36(4):667-70. PubMed ID: 7944302
[TBL] [Abstract][Full Text] [Related]
3. Nigrostriatal function in vitamin E deficiency: clinical, experimental, and positron emission tomographic studies.
Dexter DT; Brooks DJ; Harding AE; Burn DJ; Muller DP; Goss-Sampson MA; Jenner PG; Marsden CD
Ann Neurol; 1994 Mar; 35(3):298-303. PubMed ID: 8122882
[TBL] [Abstract][Full Text] [Related]
4. Striatal 18F-dopa uptake: absence of an aging effect.
Eidelberg D; Takikawa S; Dhawan V; Chaly T; Robeson W; Dahl R; Margouleff D; Moeller JR; Patlak CS; Fahn S
J Cereb Blood Flow Metab; 1993 Sep; 13(5):881-8. PubMed ID: 8360294
[TBL] [Abstract][Full Text] [Related]
5. [18F] FDOPA PET may confirm the clinical diagnosis of Parkinson's disease by imaging the nigro-striatal pathway and the sympathetic cardiac innervation: Proof-of-concept study.
Kuten J; Linevitz A; Lerman H; Freedman N; Kestenbaum M; Shiner T; Giladi N; Even-Sapir E
J Integr Neurosci; 2020 Sep; 19(3):489-494. PubMed ID: 33070528
[TBL] [Abstract][Full Text] [Related]
6. Striatal function in normal aging: implications for Parkinson's disease.
Sawle GV; Colebatch JG; Shah A; Brooks DJ; Marsden CD; Frackowiak RS
Ann Neurol; 1990 Dec; 28(6):799-804. PubMed ID: 2126684
[TBL] [Abstract][Full Text] [Related]
7. [Striatal 18F-dopa uptake measuring nigrostriatal function].
Otsuka M; Masuda K; Kato M
Nihon Rinsho; 1991 Jul; 49(7):1532-6. PubMed ID: 1909388
[No Abstract] [Full Text] [Related]
8. The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography.
Snow BJ; Bhatt M; Martin WR; Li D; Calne DB
J Neurol Neurosurg Psychiatry; 1991 Jan; 54(1):12-7. PubMed ID: 1901347
[TBL] [Abstract][Full Text] [Related]
9. [Presynaptic nigrostriatal function in Parkinson disease and Parkinson-plus syndromes. Comparative studies using positron emission tomography with L-6-(18F)fluorodopa].
Cordes M; Poewe W
Nervenarzt; 1994 Oct; 65(10):696-9. PubMed ID: 7808568
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning.
Takahashi H; Snow BJ; Bhatt MH; Peppard R; Eisen A; Calne DB
Lancet; 1993 Oct; 342(8878):1016-8. PubMed ID: 8105264
[TBL] [Abstract][Full Text] [Related]
11. Parametric imaging of the rate constant Ki using [18Fluoro]-L-dopa positron emission tomography in progressive supranuclear palsy.
Cordes M; Snow BJ; Morrison S; Sossi V; Ruth TJ; Calne DB
Neuroradiology; 1993; 35(6):404-9. PubMed ID: 8377907
[TBL] [Abstract][Full Text] [Related]
12. Reduced uptake of [¹⁸F]FDOPA PET in asymptomatic welders with occupational manganese exposure.
Criswell SR; Perlmutter JS; Videen TO; Moerlein SM; Flores HP; Birke AM; Racette BA
Neurology; 2011 Apr; 76(15):1296-301. PubMed ID: 21471467
[TBL] [Abstract][Full Text] [Related]
13. Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa.
Poyot T; Condé F; Grégoire MC; Frouin V; Coulon C; Fuseau C; Hinnen F; Dollé F; Hantraye P; Bottlaender M
J Cereb Blood Flow Metab; 2001 Jul; 21(7):782-92. PubMed ID: 11435790
[TBL] [Abstract][Full Text] [Related]
14. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Brooks DJ; Ibanez V; Sawle GV; Quinn N; Lees AJ; Mathias CJ; Bannister R; Marsden CD; Frackowiak RS
Ann Neurol; 1990 Oct; 28(4):547-55. PubMed ID: 2132742
[TBL] [Abstract][Full Text] [Related]
15. Striatal 3,4-dihydroxyphenylalanine decarboxylase in aging: disparity between postmortem and positron emission tomography studies?
Kish SJ; Zhong XH; Hornykiewicz O; Haycock JW
Ann Neurol; 1995 Aug; 38(2):260-4. PubMed ID: 7654075
[TBL] [Abstract][Full Text] [Related]
16. Persistent nigrostriatal dopaminergic abnormalities in ex-users of MDMA ('Ecstasy'): an 18F-dopa PET study.
Tai YF; Hoshi R; Brignell CM; Cohen L; Brooks DJ; Curran HV; Piccini P
Neuropsychopharmacology; 2011 Mar; 36(4):735-43. PubMed ID: 21160467
[TBL] [Abstract][Full Text] [Related]
17. Uptake of 6-[18F]fluoro-L-dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease.
Forsback S; Niemi R; Marjamäki P; Eskola O; Bergman J; Grönroos T; Haaparanta M; Haapalinna A; Rinne J; Solin O
Synapse; 2004 Feb; 51(2):119-27. PubMed ID: 14618679
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of dopaminergic presynaptic integrity: 6-[18F]fluoro-L-dopa versus 6-[18F]fluoro-L-m-tyrosine.
Doudet DJ; Chan GL; Jivan S; DeJesus OT; McGeer EG; English C; Ruth TJ; Holden JE
J Cereb Blood Flow Metab; 1999 Mar; 19(3):278-87. PubMed ID: 10078880
[TBL] [Abstract][Full Text] [Related]
19. Nigrofrontal dopaminergic function as assessed by 18F-dopa PET.
Otsuka M; Ichiya Y; Kuwabara Y; Sasaki M; Yoshida T; Fukumura T; Masuda K
Nucl Med Commun; 1995 Dec; 16(12):1021-5. PubMed ID: 8719983
[TBL] [Abstract][Full Text] [Related]
20. Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study.
Brooks DJ; Playford ED; Ibanez V; Sawle GV; Thompson PD; Findley LJ; Marsden CD
Neurology; 1992 Aug; 42(8):1554-60. PubMed ID: 1641153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
